MarketFriction

Evexia Lifecare Ltd

BSE 524444 · Trading - Chemicals
₹2.01 +4.69%
BSE close2026-10-01
Market cap₹353 Cr.
P/E190

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales10.656.7524.7221.2326.7121.7023.6122.0925.7325.2436.7930.89
Expenses12.016.7621.6620.9325.6221.5322.2921.0125.6324.9935.6930.35
Operating Profit-1.36-0.013.060.301.090.171.321.080.100.251.100.54
OPM %-12.77%-0.15%12.38%1.41%4.08%0.78%5.59%4.89%0.39%0.99%2.99%1.75%
Other Income-0.200.000.860.130.000.100.000.000.430.260.100.15
Interest0.01-0.010.490.000.050.000.410.010.000.000.000.01
Depreciation0.100.070.150.100.110.110.460.210.030.120.300.11
Profit before tax-1.67-0.073.280.330.930.160.450.860.500.390.900.57
Tax %0.00%-28.57%16.77%24.24%0.00%25.00%31.11%25.58%28.00%25.64%13.33%26.32%
Net Profit-1.67-0.052.730.240.940.120.310.630.370.290.780.42
EPS in Rs-0.03-0.000.040.000.010.000.000.000.000.000.000.00
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales341787410510010776705687110119
Expenses341767410610717973695485107117
Operating Profit-01-0-1-6-72212232
OPM %-0.3%0.7%-0.5%-0.8%-6%-68%3.2%0.8%3.5%1.9%2.6%1.7%
Other Income10131274021001
Interest000000010000
Depreciation000000000011
Profit before tax011252222122
Tax %41%32%33%30%29%33%60%56%28%55%26%
Net Profit010231111022
EPS in Rs0.000.010.010.030.060.020.010.010.020.000.010.00
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth13%1%17%26%
Compounded Profit Growth26%4%34%-7%
Stock Price CAGR3%-23%-2%-10%
Return on Equity%%%%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital46626262626262626671188188
Reserves193411131618192459272379
Borrowings5116647767056863861,222
Other Liabilities435147128146139564152677565
Total Liabilities741122192082242241421278488839201,853
Fixed Assets2229999911115014
CWIP000000020001
Investments41100011704724717879
Other Assets68109216199216215132115132148154959
Total Assets741122192082242241421278488839201,853
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity411-116-12-0-32-6-317-2-23
Cash from Investing Activity021-601-28-697-17-1853
Cash from Financing Activity-4-1211318021-1699120-28
Net Cash Flow11-2-00-001-10-02
Free Cash Flow411-116-18-0-32-8-617-2-27
CFO/OP-8,200%-9,864%-9,145%3,357%-44%52%-3%-152%-184%910%-194%-818%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days98323728617419724915673164282392
Inventory Days1975233212711812
Days Payable1873847367158172114124186195280
Cash Conversion Cycle993-142215109428054-44-1195123
Working Capital Days-1,578248250278134245192175207343143
ROCE %0%2%1%3%6%2%3%0%0%0%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters9.87%9.87%9.26%6.29%5.87%3.49%3.49%3.49%3.36%3.49%3.36%3.36%
FIIs3.36%1.43%0.00%1.03%1.49%0.16%0.16%0.00%0.47%0.47%0.12%0.00%
DIIs0.28%0.28%0.27%0.17%0.17%0.09%0.09%0.09%0.09%0.09%0.09%0.09%
Public86.48%88.42%90.47%92.50%92.48%96.25%96.25%96.40%96.07%95.94%96.41%96.54%
No. of Shareholders1,17,0291,19,0261,35,1451,28,8501,31,8431,52,2961,54,2721,51,5061,48,6851,46,4981,44,4161,44,756

Fundamentals

Market Cap₹ 353 Cr.
Current Price₹ 1.88
Stock P/E190
Book Value₹ 3.02
ROCE%
ROE%
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)26%
Compounded Profit Growth (TTM)-7%
Consolidated figures.
Valuation
Market capRs 377 Cr
Enterprise valueRs 377 Cr
P/E (TTM)202.87x
Price to sales3.18x
EV / EBITDA128.79x
EV / EBIT159.22x
EV / sales3.18x
Earnings yield0.49%
P/E, 3-year average125.70x
P/B, 3-year average1.34x
P/E, 5-year average130.35x
P/B, 5-year average1.22x
Profitability
Operating margin (excl. other income)2.60%
Operating margin (incl. other income)2.60%
EBITDA margin2.47%
Pre-tax margin1.99%
Net profit margin1.57%
Net margin, latest quarter1.36%
ROE, 3-year average0.70%
ROCE, 3-year average0.23%
ROA, 3-year average0.10%
ROE, 5-year average0.81%
ROCE, 5-year average0.89%
ROA, 5-year average0.25%
Tax rate26.36%
Growth
Sales growth (latest year)27.34%
Profit growth (latest year)295.12%
Sales CAGR, 3 years16.61%
Sales CAGR, 5 years0.68%
Profit CAGR, 3 years34.22%
Profit CAGR, 5 years4.82%
Sales growth QoQ-16.04%
Profit growth QoQ-46.15%
Sales growth YoY (latest quarter)39.84%
Profit growth YoY (latest quarter)-33.33%
Per share
EPS (TTM)Rs 0.01
EPS (latest quarter)Rs 0.00
EPS, 3-year averageRs 0.02
EPS, 5-year averageRs 0.02
Sales per shareRs 0.63
Cash flow per shareRs -0.13
Free cash flow per shareRs -0.14
Efficiency
Creditor days280 days
Cash conversion cycle123 days
Working capital days143 days
Leverage
Net debt / EBITDA0.00x
Interest coverage237.00x
Cash flow
Cash from Operating Activity (latest year)Rs -23 Cr
Cash from Investing Activity (latest year)Rs 53 Cr
Cash from Financing Activity (latest year)Rs -28 Cr
Net Cash Flow (latest year)Rs 2 Cr
Free cash flow (latest year)Rs -27 Cr
Cash from ops / profit, 5 years-3.40x
Statement figures
Net sales (TTM)Rs 119 Cr
Net sales (latest year)Rs 110 Cr
Sales (latest quarter)Rs 31 Cr
Operating profit excl. other income (latest year)Rs 3 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 3 Cr
PBDT (TTM)Rs 3 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 105 Cr
Total expenditure (latest year)Rs 107 Cr
Total income (latest year)Rs 110 Cr
Shares outstanding (crore)187.73
Ownership
Promoter holding3.36% (-0.13 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 202.9 is at the 39th percentile of its own 2.8-year range (median 216.6, low 62.2, high 397.3).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period524444Nifty 50Difference
1 week+6.3%-2.8% +9.1 pts
1 month+43.6%-6.8% +50.4 pts
3 months+20.4%-7.6% +28.0 pts
3 years+1.0%+14.2% -13.2 pts
5 years-71.5%+27.9% -99.4 pts

Red flags

explainWeak cash conversion Cash from operations was -256% of net profit over the last 3 years
explainShare dilution Share count up 0% in a year, 183% in three
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹31 Cr +39.8% vs Jun 2025. Net profit ₹0 Cr -33.3%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Uniphos Enterprises Ltd62230.70.80 %
Veritas (India) Ltd3971.52 %
Vinyl Chemicals (I) Ltd39521.114.9 %
Bhavik Enterprises Ltd31623.314.3 %
A-1 Ltd26931.411.6 %
Shiv Texchem Ltd2573.3115.3 %
Dhariwalcorp Ltd25437.719.7 %
Shankar Lal Rampal Dye-Chem Ltd24913.514.0 %
Mysore Petro Chemicals Ltd867.950.34 %
Aureate Tradde Ltd6111.620.5 %
Yash Chemex Ltd5625.36.30 %
Laffans Petrochemicals Ltd23-2.85 %
Citichem India Ltd1211.97.18 %
CHD Chemicals Ltd6-0.42 %
Patron Exim Ltd5-2.69 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Evexia Lifecare Ltd?

Evexia Lifecare Ltd (524444) has a market capitalisation of Rs 353 Cr. at the 2026-10-01 close.

What is the P/E ratio of Evexia Lifecare Ltd?

Evexia Lifecare Ltd trades at a P/E of 190 on trailing twelve-month profit, at the 2026-10-01 close.

What were Evexia Lifecare Ltd's latest quarterly results?

In the Jun 2026 quarter, Evexia Lifecare Ltd sales was Rs 31 Cr (+39.8% vs Jun 2025) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03